Characteristics and outcomes of patients with COVID-19 in Hainan, South China

Yamei Zheng1, Yunsuo Gao2, Biao Wu3

  • 1Pulmonary and Critical Care Medicine.

Medicine
|March 17, 2021
PubMed

Insights

Clinical outcomes for COVID-19 travelers and local residents in Hainan were similar, suggesting the climate did not significantly impact disease presentation or severity. Avoid travel to tourist areas during outbreaks.

Area of Science:

  • Infectious Diseases
  • Clinical Medicine
  • Epidemiology

Background:

  • Hainan province, a popular tourist destination, experienced both imported and local cases of COVID-19.
  • Understanding the clinical profile of COVID-19 patients in diverse settings is crucial for public health management.

Purpose of the Study:

  • To investigate the clinical characteristics and outcomes of COVID-19 patients in Hainan, China.
  • To compare clinical data between local residents and travelers infected with COVID-19.

Main Methods:

  • Retrospective assessment of 70 COVID-19 patients hospitalized in Hainan.
  • Analysis of routine blood tests, blood gas, CT imaging, and viral nucleic acid detection.
  • Stratification of patients into local resident and traveler groups for comparative analysis.

Main Results:

  • No significant differences were observed in clinical features, severity, laboratory findings (leukocyte, lymphocyte, neutrophil counts), or outcomes between local residents and travelers.
  • Common symptoms included fever (78.6%) and cough (67.1%), with 12.9% experiencing chest dyspnea.
  • The majority of cases were mild/common (78.6%), with 12.9% classified as severe/critical.

Conclusions:

  • The warm and humid climate of Hainan did not appear to significantly influence COVID-19 patient characteristics or outcomes.
  • Findings suggest that COVID-19 presents similarly across different population groups in this region.
  • Recommendations include avoiding travel to tourist areas during infectious disease outbreaks.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
471
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
569
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.6K